Antisoma News
Most Popular Antisoma Story
ASA404 - The Top 10 Phase III Failures
The drug: ASA404The disease: Lung cancerThe company: Antisoma partnered with Novartis You have to give Antisoma CEO Glyn Edwards credit. When the Phase III lung cancer data on ASA404 turned so bad in Read more...
Latest Headlines
- August 30, 2011
- February 28, 2011
- January 31, 2011
- November 11, 2010
- October 21, 2010
- April 6, 2010
- March 29, 2010
- August 7, 2009
- May 12, 2009
- March 25, 2009
- May 16, 2008
- April 14, 2008
- February 21, 2008
- January 10, 2008
- November 20, 2007
- September 11, 2007
- August 22, 2007
- July 12, 2007
- November 7, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
